QELBREE 200 mg/1 (Viloxazine Hydrochloride CAPSULE, EXTENDED RELEASE) 200 mg/1

QELBREE 200 mg is an extended-release capsule containing viloxazine hydrochloride, used for managing certain mental health conditions. This medication is designed to provide sustained relief and is manufactured by Supernus Pharmaceuticals, Inc.

Strength

200 mg/1

Pack Size

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-30)

Manufacturer / TM Owner

Supernus Pharmaceuticals, Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

QELBREE 200 mg is primarily used to address symptoms associated with attention deficit hyperactivity disorder (ADHD). Viloxazine hydrochloride, the active ingredient, works to help improve focus and reduce impulsivity. This medication is often prescribed as part of a comprehensive treatment plan that may include behavioral therapy and lifestyle modifications.

Side Effects

Common effects of QELBREE 200 mg may include improvements in concentration and a reduction in hyperactive behaviors. Some individuals may experience mild side effects such as nausea, headache, or insomnia. These effects can vary and are not experienced by everyone who takes the medication.

Precautions & Warnings

QELBREE 200 mg should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be shared with others, even if they have similar symptoms.

Avoid Interactions

QELBREE 200 mg may interact with certain medications, including those that affect the central nervous system. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol consumption should be discussed with a healthcare professional.

Frequently Asked Questions

QELBREE 200 mg is used to manage symptoms of attention deficit hyperactivity disorder (ADHD).

QELBREE 200 mg is an extended-release capsule that should be taken orally, typically once daily, as directed by a healthcare professional.

Common side effects may include nausea, headache, and insomnia. These effects can vary and are not experienced by everyone.

QELBREE 200 mg may interact with certain medications, so it is important to consult a healthcare professional before combining it with other drugs.

The safety of QELBREE 200 mg for long-term use should be discussed with a healthcare professional, who can provide guidance based on individual health needs.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.